5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Pericardial Effusion
Pericardial effusion refers to the abnormal accumulation of fluid in the pericardial sac, the double-walled sac that surrounds the heart. This condition can result from various causes, including infections, inflammation, trauma, or underlying medical conditions. As the fluid accumulates, it puts pressure on the heart, potentially impacting its ability to function optimally. Common symptoms of pericardial effusion include chest pain, shortness of breath, and fatigue. Diagnosis often involves imaging tests such as echocardiography, and treatment may vary based on the underlying cause. In some cases, medical intervention, such as drainage of the fluid or anti-inflammatory medications, may be necessary to alleviate symptoms and prevent complications. Pericardial effusion underscores the importance of timely medical attention and intervention in managing cardiovascular health.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain